These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Identification of single amino acid residues essential for the binding of lipopolysaccharide (LPS) to LPS binding protein (LBP) residues 86-99 by using an Ala-scanning library. Reyes O; Vallespi MG; Garay HE; Cruz LJ; González LJ; Chinea G; Buurman W; Araña MJ J Pept Sci; 2002 Apr; 8(4):144-50. PubMed ID: 11991204 [TBL] [Abstract][Full Text] [Related]
4. A synthetic lipopolysaccharide-binding peptide based on amino acids 27-39 of serum amyloid P component inhibits lipopolysaccharide-induced responses in human blood. de Haas CJ; van der Tol ME; Van Kessel KP; Verhoef J; Van Strijp JA J Immunol; 1998 Oct; 161(7):3607-15. PubMed ID: 9759883 [TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of truncated human lipopolysaccharide-binding protein in Escherichia coli. Kohara J; Tsuneyoshi N; Gauchat JF; Kimoto M; Fukudome K Protein Expr Purif; 2006 Oct; 49(2):276-83. PubMed ID: 16839777 [TBL] [Abstract][Full Text] [Related]
6. Recombinant factor C competes against LBP to bind lipopolysaccharide and neutralizes the endotoxicity. Li P; Ho B; Ding JL J Endotoxin Res; 2007; 13(3):150-7. PubMed ID: 17621557 [TBL] [Abstract][Full Text] [Related]
7. Structure of a synthetic fragment of the lipopolysaccharide (LPS) binding protein when bound to LPS and design of a peptidic LPS inhibitor. Pristovsek P; Simcic S; Wraber B; Urleb U J Med Chem; 2005 Dec; 48(24):7911-4. PubMed ID: 16302828 [TBL] [Abstract][Full Text] [Related]
8. Comparison of lipopolysaccharide-binding functions of CD14 and MD-2. Koraha J; Tsuneyoshi N; Kimoto M; Gauchat JF; Nakatake H; Fukudome K Clin Diagn Lab Immunol; 2005 Nov; 12(11):1292-7. PubMed ID: 16275943 [TBL] [Abstract][Full Text] [Related]
9. Binding of lipopolysaccharide (LPS) to CHO cells does not correlate with LPS-induced NF-kappaB activation. Hamann L; Schumann RR; Flad HD; Brade L; Rietschel ET; Ulmer AJ Eur J Immunol; 2000 Jan; 30(1):211-6. PubMed ID: 10602043 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of LPS-responses by synthetic peptides derived from LBP associates with the ability of the peptides to block LBP-LPS interaction. Araña Mde J; Vallespi MG; Chinea G; Vallespi GV; Rodriguez-Alonso I; Garay HE; Buurman WA; Reyes O J Endotoxin Res; 2003; 9(5):281-91. PubMed ID: 14577844 [TBL] [Abstract][Full Text] [Related]
11. Alexidine and chlorhexidine bind to lipopolysaccharide and lipoteichoic acid and prevent cell activation by antibiotics. Zorko M; Jerala R J Antimicrob Chemother; 2008 Oct; 62(4):730-7. PubMed ID: 18635521 [TBL] [Abstract][Full Text] [Related]
13. A synthetic peptide derived from bactericidal/permeability-increasing protein neutralizes endotoxin in vitro and in vivo. Jiang Z; Hong Z; Guo W; Xiaoyun G; Gengfa L; Yongning L; Guangxia X Int Immunopharmacol; 2004 Apr; 4(4):527-37. PubMed ID: 15099530 [TBL] [Abstract][Full Text] [Related]
14. Screening of mimetic peptides for CD14 binding site with LBP and antiendotoxin activity of mimetic peptide in vivo and in vitro. Xu Z; Qian GS; Li Q; Feng QJ; Wu GM; Li KL Inflamm Res; 2009 Jan; 58(1):45-53. PubMed ID: 19115038 [TBL] [Abstract][Full Text] [Related]
15. Reactivity of murine and human recombinant LPS-binding protein (LBP) within LPS and gram negative bacteria. Lengacher S; Jongeneel CV; Le Roy D; Lee JD; Kravchenko V; Ulevitch RJ; Glauser MP; Heumann D J Inflamm; 1995-1996; 47(4):165-72. PubMed ID: 9144073 [TBL] [Abstract][Full Text] [Related]
16. High-throughput characterization of lipopolysaccharide-binding proteins using mass spectrometry. Kim YG; Yang YH; Kim BG J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Dec; 878(31):3323-6. PubMed ID: 21035409 [TBL] [Abstract][Full Text] [Related]
17. Low potency of Chlamydophila LPS to activate human mononuclear cells due to its reduced affinities for CD14 and LPS-binding protein. Tsutsumi-Ishii Y; Shimada K; Daida H; Toman R; Nagaoka I Int Immunol; 2008 Feb; 20(2):199-208. PubMed ID: 18056918 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of lipid A-mediated type I interferon induction by bactericidal/permeability-increasing protein (BPI). Azuma M; Matsuo A; Fujimoto Y; Fukase K; Hazeki K; Hazeki O; Matsumoto M; Seya T Biochem Biophys Res Commun; 2007 Mar; 354(2):574-8. PubMed ID: 17239348 [TBL] [Abstract][Full Text] [Related]
19. Modulatory effects of sCD14 and LBP on LPS-host cell interactions. Kitchens RL; Thompson PA J Endotoxin Res; 2005; 11(4):225-9. PubMed ID: 16176659 [TBL] [Abstract][Full Text] [Related]
20. The BPI/LBP family of proteins: a structural analysis of conserved regions. Beamer LJ; Carroll SF; Eisenberg D Protein Sci; 1998 Apr; 7(4):906-14. PubMed ID: 9568897 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]